首页> 外文OA文献 >Protein Reporter Bioassay Systems for the Phenotypic Screening of Candidate Drugs: A Mouse Platform for Anti-Aging Drug Screening
【2h】

Protein Reporter Bioassay Systems for the Phenotypic Screening of Candidate Drugs: A Mouse Platform for Anti-Aging Drug Screening

机译:用于候选药物表型筛选的蛋白质报道生物测定系统:抗衰老药物筛选的小鼠平台

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent drug discovery efforts have utilized high throughput screening (HTS) of large chemical libraries to identify compounds that modify the activity of discrete molecular targets. The molecular target approach to drug screening is widely used in the pharmaceutical and biotechnology industries, because of the amount of knowledge now available regarding protein structure that has been obtained by computer simulation. The molecular target approach requires that the structure of target molecules, and an understanding of their physiological functions, is known. This approach to drug discovery may, however, limit the identification of novel drugs. As an alternative, the phenotypic- or pathway-screening approach to drug discovery is gaining popularity, particularly in the academic sector. This approach not only provides the opportunity to identify promising drug candidates, but also enables novel information regarding biological pathways to be unveiled. Reporter assays are a powerful tool for the phenotypic screening of compound libraries. Of the various reporter genes that can be used in such assays, those encoding secreted proteins enable the screening of hit molecules in both living cells and animals. Cell- and animal-based screens enable simultaneous evaluation of drug metabolism or toxicity with biological activity. Therefore, drug candidates identified in these screens may have increased biological efficacy and a lower risk of side effects in humans. In this article, we review the reporter bioassay systems available for phenotypic drug discovery.
机译:最近的药物发现工作已利用大型化学文库的高通量筛选(HTS)来鉴定修饰离散分子靶标活性的化合物。药物筛选的分子靶标方法已广泛用于制药和生物技术行业,这是因为目前通过计算机模拟已获得了有关蛋白质结构的大量知识。分子靶方法要求靶分子的结构及其对生理功能的了解是已知的。但是,这种发现药物的方法可能会限制新药的鉴定。作为替代方案,用于药物发现的表型或途径筛选方法正变得越来越流行,特别是在学术领域。这种方法不仅提供了确定有前途的候选药物的机会,而且还使有关生物学途径的新颖信息得以揭示。记者分析是化合物库表型筛选的强大工具。在可用于此类测定的各种报告基因中,编码分泌蛋白的那些能够在活细胞和动物中筛选命中分子。基于细胞和动物的筛选可以同时评估药物代谢或具有生物活性的毒性。因此,在这些筛选中鉴定出的候选药物可能具有更高的生物学功效,并降低了人类副作用的风险。在本文中,我们回顾了可用于表型药物发现的报告基因生物测定系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号